Published in J Steroid Biochem Mol Biol on February 18, 1998
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12
The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci U S A (2002) 5.98
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev (2015) 2.51
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res (2011) 1.32
Identification of novel androgen receptor target genes in prostate cancer. Mol Cancer (2007) 1.15
Androgen responsive intronic non-coding RNAs. BMC Biol (2007) 1.07
The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. BMC Cell Biol (2002) 1.06
Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator. Proc Natl Acad Sci U S A (2000) 1.05
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer. EMBO J (2012) 0.94
An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells. J Cell Sci (2008) 0.93
Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cells. Neoplasia (2003) 0.83
APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation. J Steroid Biochem Mol Biol (2007) 0.81
The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers. Am J Hum Genet (2001) 0.79
Androgen receptor coactivators that inhibit prostate cancer growth. Am J Clin Exp Urol (2014) 0.78
A Role for Androgens in Epithelial Proliferation and Formation of Glands in the Mouse Uterus. Endocrinology (2016) 0.77
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 10.04
Age at first birth and breast cancer risk. Bull World Health Organ (1970) 6.16
The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect (1995) 5.37
Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect (1996) 4.93
p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect (1991) 4.52
Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology (2012) 3.98
A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell (2001) 3.97
Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res (1985) 3.44
The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect (1994) 3.12
Lactation and cancer of the breast. A summary of an international study. Bull World Health Organ (1970) 3.04
Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect (2001) 3.00
In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod (2001) 2.96
Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity. Oncogene (2008) 2.72
The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ Health Perspect (2001) 2.71
The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem (1985) 2.63
Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol (1974) 2.52
A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer (1986) 2.37
An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol (1998) 2.13
Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis (2005) 2.05
Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect (1999) 2.03
Organization and expression strategy of the ambisense genome of densonucleosis virus of Galleria mellonella. J Virol (2003) 1.95
Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology (1991) 1.78
twine, a cdc25 homolog that functions in the male and female germline of Drosophila. Cell (1992) 1.77
Age at any birth and breast cancer risk. Int J Cancer (1983) 1.65
Bovine pancreatic peptide: action on gastric and pancreatic secretion in dogs. Am J Physiol (1977) 1.63
Standardized quantitative enzyme-linked immunoassay for antibodies to Toxoplasma gondii. J Clin Microbiol (1980) 1.59
Candidate hormones of the gut. VI. Bovine pancreatic polypeptide (BPP) and avian pancreatic polypeptide (APP). Gastroenterology (1974) 1.54
Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicol Sci (2000) 1.52
Genome organization of the densovirus from Bombyx mori (BmDNV-1) and enzyme activity of its capsid. J Gen Virol (2001) 1.51
Quantitative comparisons of in vitro assays for estrogenic activities. Environ Health Perspect (2000) 1.49
Detection of Dekkera-Brettanomyces strains in sherry by a nested PCR method. Appl Environ Microbiol (1996) 1.43
Failure of fluconazole therapy in Candida krusei fungemia. Eur J Clin Microbiol Infect Dis (1991) 1.42
Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer Di(2-ethylhexyl) phthalate. Environ Health Perspect (2001) 1.42
Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res (1989) 1.41
Fatty and mycolic acids of Mycobacterium malmoense. J Clin Microbiol (1988) 1.40
Epidemiologic characteristics of cancer of the breast in Taiwan. Cancer (1971) 1.39
Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab (1987) 1.37
Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells. Biochem Biophys Res Commun (1984) 1.37
The two faces of janus: sex steroids as mediators of both cell proliferation and cell death. J Natl Cancer Inst (2001) 1.37
Measurement of pregnancy-associated plasma proteins during human gestation. J Clin Invest (1974) 1.36
The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem (1994) 1.35
A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer (1988) 1.35
Differentiating Taenia solium and Taenia saginata infections by simple hematoxylin-eosin staining and PCR-restriction enzyme analysis. J Clin Microbiol (2000) 1.34
Genome organization of Casphalia extranea densovirus, a new iteravirus. Virology (2002) 1.33
Translational control of the cdc25 cell cycle phosphatase: a molecular mechanism coupling mitosis to cell growth. J Cell Sci (1999) 1.31
Development of a marker of estrogenic exposure in human serum. Clin Chem (1995) 1.26
Placental localization of human pregnancy--associated plasma proteins. Science (1976) 1.23
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses. Blood (2000) 1.23
Somatic mutation theory of carcinogenesis: why it should be dropped and replaced. Mol Carcinog (2000) 1.19
Developing a marker of exposure to xenoestrogen mixtures in human serum. Environ Health Perspect (1997) 1.18
On physicalism and downward causation in developmental and cancer biology. Acta Biotheor (2008) 1.18
Cervical spine disease and dysphagia. Four new cases and a review of the literature. Am J Gastroenterol (1981) 1.18
Cell proliferation of estrogen-sensitive cells: the case for negative control. Endocr Rev (1987) 1.17
Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology (1978) 1.17
Prenatal exposure to low doses of bisphenol A alters the periductal stroma and glandular cell function in the rat ventral prostate. Biol Reprod (2001) 1.16
Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology (1985) 1.16
A plasma-borne specific inhibitor of the proliferation of human estrogen-sensitive breast tumor cells (estrocolyone-I). J Steroid Biochem Mol Biol (1992) 1.15
Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes. Diabetologia (2011) 1.15
Centromere formation in mouse cells cotransformed with human DNA and a dominant marker gene. Proc Natl Acad Sci U S A (1991) 1.15
Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology (1997) 1.15
Small cell osteosarcoma. A clinicopathologic study of 27 cases. Cancer (1989) 1.15
Simple standardized enzyme-linked immunosorbent assay for human antibodies to Entamoeba histolytica. J Clin Microbiol (1981) 1.12
Retrospective study on nasopharyngeal carcinoma. J Natl Cancer Inst (1973) 1.11
Identification of de novo mutations and rare variants in hypoplastic left heart syndrome. Clin Genet (2011) 1.10
Peutz-Jeghers syndrome in children: report of two cases and review of the literature. J Pediatr Surg (1983) 1.10
Maternal age and birth rank of women with breast cancer. J Natl Cancer Inst (1980) 1.08
Hypoglycemic activity of olive leaf. Planta Med (1992) 1.07
Gene of type II autosomal dominant retinitis pigmentosa maps on the long arm of chromosome 3. Am J Med Genet (1990) 1.07
Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator. Proc Natl Acad Sci U S A (2000) 1.05
Mitochondrial DNA loss caused by ethanol in Saccharomyces flor yeasts. Appl Environ Microbiol (1997) 1.02
Fractal analysis in a systems biology approach to cancer. Semin Cancer Biol (2011) 1.02
Prevalence of Toxoplasma gondii in cats from Colombia, South America and genetic characterization of T. gondii isolates. Vet Parasitol (2006) 1.01
A thin-layer chromatographic method for separating methyl esters of mycobacterial mycolic acids. Acta Pathol Microbiol Immunol Scand B (1986) 1.01
Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infect Immun (2000) 1.01
Action of acetylsalicylic acid and glucagon on acid secretion mucosal blood flow, bleeding and net ionic efflux in the fundic pouch of pentagastrin-stimulated dogs. Arch Int Pharmacodyn Ther (1974) 1.01
Urine oestrogen profiles of Asian and North American women. Int J Cancer (1974) 1.00
Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells. Endocrinology (1991) 0.99
Electrophoretic karyotype of budding yeasts with intact cell wall. Nucleic Acids Res (1993) 0.99
Control of cell proliferation: evidence for negative control on estrogen-sensitive T47D human breast cancer cells. Cancer Res (1986) 0.98
Three pregnancy-associated human plasma proteins: purification, monospecific antisera and immunological indentification. Int Arch Allergy Appl Immunol (1974) 0.98
Oestrogen profiles of Asian and North American women. Lancet (1971) 0.98
Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response. Oncol Res (1995) 0.97